Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093528046> ?p ?o ?g. }
- W2093528046 endingPage "539" @default.
- W2093528046 startingPage "532" @default.
- W2093528046 abstract "<b><i>Background:</i></b> Stroke is one of the major causes of disability in the adult population and represents a heavy social and economic burden. Currently available therapeutic tools to support the recovery of impaired brain functions are quite limited. Animal studies have demonstrated that neuronal replacement and partial reconstruction of neural circuitry or modulation of the recovery process is possible with cell transplantation in the damaged adult brain. Stem cell therapy (SCT) may promote functional recovery also in stroke patients, thereby improving quality of life and reducing costs. Our aim was to estimate the potential societal value of SCT in stroke patients. <b><i>Methods:</i></b> We created a decision-analytic model in Microsoft Excel 2010 to assess life-long costs and quality-adjusted life years (QALYs) of SCT versus standard care for stroke patients from a societal perspective. The model structure consisted of 7 health states in accordance with the modified Rankin Scale (mRS). We modeled for age (55, 65, and 75 years), functional status at discharge (mRS 2, 3, and 4), effectiveness of SCT (50 and 25% increase in the probability to improve 1 mRS grade), mode of stem cell administration, risk of recurrent stroke, complications of intervention, and use of immunosuppressive drugs. The difference between an assumed societal willingness to pay for a QALY gain in Sweden (110,400 USD) and the cost per QALY gain resulting from the model was interpreted as the value of SCT. <b><i>Results:</i></b> Increased survival (1.06 life years) and improved functional status gave rise to an estimated gain of 1.34 QALY in a cohort of patients aged 55 with mRS 2 at hospital discharge. Although the SCT intervention increased costs by 64,014 USD (excluding cost of stem cells), the costs of intervention were offset mainly by decreased productivity losses. In total, the intervention saved 19,055 USD, i.e., at a price of 19,055 USD for stem cells, the SCT would be cost neutral. The societal value of SCT was 166,500 USD. <b><i>Conclusions:</i></b> The application of the health-economic model to Sweden shows that in younger stroke patients with moderate disability, the societal value of SCT given a zero price of stem cells is 166,500 USD. Although the transplantation itself is more costly, SCT offers potential for cost offset and cost savings in a long-term perspective by reducing the disability after stroke. The therapy appeared cost effective under a wide range of assumptions. Hence, further research and development in stem cells suitable for stroke therapy could potentially produce great value to society." @default.
- W2093528046 created "2016-06-24" @default.
- W2093528046 creator A5008464319 @default.
- W2093528046 creator A5012111660 @default.
- W2093528046 creator A5019420693 @default.
- W2093528046 creator A5049171167 @default.
- W2093528046 creator A5066365730 @default.
- W2093528046 creator A5067654386 @default.
- W2093528046 creator A5075877585 @default.
- W2093528046 date "2012-01-01" @default.
- W2093528046 modified "2023-10-17" @default.
- W2093528046 title "Societal Value of Stem Cell Therapy in Stroke – A Modeling Study" @default.
- W2093528046 cites W141766886 @default.
- W2093528046 cites W1514179657 @default.
- W2093528046 cites W1773635590 @default.
- W2093528046 cites W1965125639 @default.
- W2093528046 cites W1972463800 @default.
- W2093528046 cites W2007543609 @default.
- W2093528046 cites W2026283799 @default.
- W2093528046 cites W2029584195 @default.
- W2093528046 cites W2030472502 @default.
- W2093528046 cites W2039402076 @default.
- W2093528046 cites W2052118012 @default.
- W2093528046 cites W2072674104 @default.
- W2093528046 cites W2084869945 @default.
- W2093528046 cites W2107499423 @default.
- W2093528046 cites W2116769108 @default.
- W2093528046 cites W2127557926 @default.
- W2093528046 cites W2131719169 @default.
- W2093528046 cites W2137797595 @default.
- W2093528046 cites W2144768520 @default.
- W2093528046 cites W2155945484 @default.
- W2093528046 cites W2163987873 @default.
- W2093528046 cites W2168698324 @default.
- W2093528046 cites W2169176983 @default.
- W2093528046 cites W2004169695 @default.
- W2093528046 cites W2517298661 @default.
- W2093528046 doi "https://doi.org/10.1159/000337765" @default.
- W2093528046 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22571941" @default.
- W2093528046 hasPublicationYear "2012" @default.
- W2093528046 type Work @default.
- W2093528046 sameAs 2093528046 @default.
- W2093528046 citedByCount "11" @default.
- W2093528046 countsByYear W20935280462012 @default.
- W2093528046 countsByYear W20935280462014 @default.
- W2093528046 countsByYear W20935280462015 @default.
- W2093528046 countsByYear W20935280462016 @default.
- W2093528046 countsByYear W20935280462017 @default.
- W2093528046 countsByYear W20935280462019 @default.
- W2093528046 countsByYear W20935280462020 @default.
- W2093528046 countsByYear W20935280462023 @default.
- W2093528046 crossrefType "journal-article" @default.
- W2093528046 hasAuthorship W2093528046A5008464319 @default.
- W2093528046 hasAuthorship W2093528046A5012111660 @default.
- W2093528046 hasAuthorship W2093528046A5019420693 @default.
- W2093528046 hasAuthorship W2093528046A5049171167 @default.
- W2093528046 hasAuthorship W2093528046A5066365730 @default.
- W2093528046 hasAuthorship W2093528046A5067654386 @default.
- W2093528046 hasAuthorship W2093528046A5075877585 @default.
- W2093528046 hasBestOaLocation W20935280461 @default.
- W2093528046 hasConcept C112930515 @default.
- W2093528046 hasConcept C126322002 @default.
- W2093528046 hasConcept C127413603 @default.
- W2093528046 hasConcept C159110408 @default.
- W2093528046 hasConcept C1862650 @default.
- W2093528046 hasConcept C2776361831 @default.
- W2093528046 hasConcept C2778818304 @default.
- W2093528046 hasConcept C2779951463 @default.
- W2093528046 hasConcept C2780645631 @default.
- W2093528046 hasConcept C2780931571 @default.
- W2093528046 hasConcept C2908647359 @default.
- W2093528046 hasConcept C2911091166 @default.
- W2093528046 hasConcept C3019080777 @default.
- W2093528046 hasConcept C3020199598 @default.
- W2093528046 hasConcept C541997718 @default.
- W2093528046 hasConcept C64332521 @default.
- W2093528046 hasConcept C71924100 @default.
- W2093528046 hasConcept C78519656 @default.
- W2093528046 hasConcept C99454951 @default.
- W2093528046 hasConceptScore W2093528046C112930515 @default.
- W2093528046 hasConceptScore W2093528046C126322002 @default.
- W2093528046 hasConceptScore W2093528046C127413603 @default.
- W2093528046 hasConceptScore W2093528046C159110408 @default.
- W2093528046 hasConceptScore W2093528046C1862650 @default.
- W2093528046 hasConceptScore W2093528046C2776361831 @default.
- W2093528046 hasConceptScore W2093528046C2778818304 @default.
- W2093528046 hasConceptScore W2093528046C2779951463 @default.
- W2093528046 hasConceptScore W2093528046C2780645631 @default.
- W2093528046 hasConceptScore W2093528046C2780931571 @default.
- W2093528046 hasConceptScore W2093528046C2908647359 @default.
- W2093528046 hasConceptScore W2093528046C2911091166 @default.
- W2093528046 hasConceptScore W2093528046C3019080777 @default.
- W2093528046 hasConceptScore W2093528046C3020199598 @default.
- W2093528046 hasConceptScore W2093528046C541997718 @default.
- W2093528046 hasConceptScore W2093528046C64332521 @default.
- W2093528046 hasConceptScore W2093528046C71924100 @default.
- W2093528046 hasConceptScore W2093528046C78519656 @default.
- W2093528046 hasConceptScore W2093528046C99454951 @default.